Answer
Plasma potassium should be monitored during initial Neo-Cytamen (hydroxocobalamin) treatment because cardiac arrhythmias secondary to hypokalaemia have been reported during initial therapy.
Sources for this answer
- SmPC - Neo-Cytamen 1000 mcg/ml solution for injectionRPH Pharmaceuticals AB · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked